10X Genomics Inc Capital Reinvestment Ratio
10X Genomics Inc capital reinvestment ratio. 10X Genomics Inc (TXG) has a Capital Reinvestment Ratio of 0.09x as of June 2026, meaning it reinvests 0% of its operating cash flow ($16.97 Million) in capital expenditures ($1.59 Million). See 10X Genomics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of 10X Genomics Inc (2019–2025)
Capital reinvestment ratio of 10X Genomics Inc from 2019 to 2025. This chart tracks 10X Genomics Inc's Capital Reinvestment Ratio across 3 annual periods. See 10X Genomics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
10X Genomics Inc Capital Reinvestment Ratio by Year (2019–2025)
10X Genomics Inc capital reinvestment ratio by year from 2019 to 2025. For the full cash flow conversion analysis, see TXG cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | $136.05 Million | $5.93 Million | ▼ -97.7% |
| 2024 | 1.86x | $6.66 Million | $12.39 Million | ▲ +50.6% |
| 2019 | 1.24x | $34.63 Million | $42.77 Million | — |